(Q46398322)

21 December 2017

title

Beneficial effect of early initiation of lipid-lowering therapy following renal transplantation (English)

1 reference

21 December 2017

author

Alan Jardine

3

1 reference

21 December 2017

author name string

Hallvard Holdaas

1

1 reference

21 December 2017

Bengt Fellström

2

1 reference

21 December 2017

Gudrun Nyberg

4

1 reference

21 December 2017

Carola Grönhagen-Riska

5

1 reference

21 December 2017

Sören Madsen

6

1 reference

21 December 2017

Hans-Hellmut Neumayer

7

1 reference

21 December 2017

Edward Cole

8

1 reference

21 December 2017

Bart Maes

9

1 reference

21 December 2017

Patrice Ambühl

10

1 reference

21 December 2017

John O Logan

11

1 reference

21 December 2017

Beatrix Staffler

12

1 reference

21 December 2017

Claudio Gimpelewicz

13

1 reference

21 December 2017

ALERT Study Group

14

1 reference

21 December 2017

language of work or name

English

0 references

publication date

22 March 2005

1 reference

21 December 2017

Nephrology Dialysis Transplantation

published in

1 reference

21 December 2017

volume

20

1 reference

21 December 2017

issue

5

1 reference

21 December 2017

page(s)

974-980

1 reference

21 December 2017

Diagnosis and Therapy of Coronary Artery Disease in Renal Failure, End-Stage Renal Disease, and Renal Transplant Populations

cites work

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH735

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH735

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH735

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH735

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH735

Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH735

Hyperlipidemia in solid organ transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH735

Effect of fluvastatin on acute renal allograft rejection: a randomized multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH735

Patient survival after renal transplantation III: the effects of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH735

Risk for myopathy with statin therapy in high-risk patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH735

Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH735

21 January 2018

Identifiers

DOI

10.1093/NDT/GFH735

1 reference

21 December 2017

1 reference

21 December 2017